In a nutshell.. Company IPO'd 8 years ago.. raised over $300M from the market.. culmulative earnings to date have been less $10M (generous guesstimate).. so the return on investment (ROI) has been 3%.. taking into account inflation.. your ROI is -21%.
Theres all this talk about guranteed revenues - but nothing is guranteed especially in Europe of all places for a marginally effective drug (as stated by EMA/PBAC) at 10k p.a price tag.
The market has rightly said.. show me the money.
Add to My Watchlist
What is My Watchlist?
